NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000023764

Registered date:25/08/2016

Development of objective measures for depression, bipolar disorder and dementia by quantifying facial expression, body movement, and voice data during clinical interview and daily activity utilizing wearable device

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studied1. Patients with depressive disorder or bipolar disorder 2. Patients with dementia, mild cognitive impairment, or subjective cognitive impairment 3. Healthy volunteers
Date of first enrollment2016/09/01
Target sample size500
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)1)Collect demographical/clinical characteristics from chart, participant and treating physician 2)Video/infrared/voice recording during a 10-minute conversation with psychiatrist and/or psychologist. Total number of recordings will be up to 10 times during the study period. Recording will be done during the doctor visit and the interval of the recording will not be fixed 3)Clinical severity assessment using rating scales as follows. Hamilton Rating Scale for Depression (HAM-D): 20 minutes* Montgomery Asberg Depression Rating Scale (MADRS): 10 minutes* Young mania rating scale (YMRS): 10 minutes* Beck depression inventory (BDI): 3 minutes* Pittsburgh sleep quality index (PSQI): 2 minutes* Clinical Dementia Rating(CDR): 15 minutes** Mini-mental Scale Examination (MMSE): 15 minutes** Wechsler Memory Scale-Logical Memory Subtest: 5 minutes** Clock drawing test (CDT): 3 minutes** Neuropsychiatric Inventory (NPI): 10 minutes** Geriatric Depression Scale (GDS): 5 minutes** (*Applied to patients with depression and bipolar disorder. **Applied to patients with dementia, mild cognitive impairment, or subjective cognitive impairment. All rating scales including * and ** will be applied to healthy volunteers) 4)To those who are willing to consent to the optional part: Wear wrist band type sensor to collect daily activity data until the next assessment. 5)except healthy volunteers are diagnosed using Structured Clinical Interview for DSM-IV-TR (SCID) any time during the follow up.

Outcome(s)

Primary OutcomeComprehensive severity score based on facial expression, body movement, voice, and daily activity data produced by machine learning
Secondary Outcome1)Machine learning-severity score based on facial expression data 2)Machine learning-severity score based on body movement data 3)Machine learning-severity score based on voice data (mainly using the acoustic features) 4)Machine learning-severity score based on voice data (mainly using the features such as speed of speech, time to reply) 5)Machine learning-severity score based on text data 6)Machine learning-severity score based on daily activity data

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaExclusion Criteria: As patients (1) Patients whose illness can be exacerbated by interview of the study. (2) Patients who have comorbidities that can interfere with measurements in the study; such as patients with facial palsy or involuntary movement, patients with quadriplegic palsy or involuntary motion, patients with dysphonia by laryngectomy. (3) Those who are considered to be ineligible by the PI or investigators.

Related Information

Contact

public contact
Name Momoko Kitazawa
Address 35 Shinanomachi, Shinjuku-ku, Tokyo, JAPAN Japan 160-8582
Telephone 03-5363-3492
E-mail m.kitazawa@keio.jp
Affiliation Keio University School of Medicine Department of Neuropsychiatry PROMPT office
scientific contact
Name Kishimoto Taishiro
Address Roppongi Hills North Tower 7F, 6-2-31 Roppongi, minato-ku, Tokyo, Japan Japan
Telephone 03-5786-0006
E-mail tkishimoto@keio.jp
Affiliation Keio University School of Medicine Hills Joint Research Laboratory for Future Preventive Medicine and Wellnes